Sarcopenia Treatment Market Increasing Vitamin Deficiency as a Result of Aging are Expected to Create High Demand
Sarcopenia, a condition commonly referred to as Sarcoptic Squamous Cell Disease (SCMD), is an aging-related disorder characterized by the rapid loss of sarcoplasmic muscle tissue, resulting in abnormal muscle weakness and decreased muscular performance. Sarcopenia primarily affects older men and women (although cases are also reported among children). The diagnosis of Sarcopenia can be based on physical symptoms such as muscle weakness, decreased muscle performance, joint pain, decreased physical functioning, weight gain, increased body fat, decreased libido, and increased aging. Other signs and symptoms include bone pain, fractures, and an increased risk of infection. Sarcopenia can cause significant disabilities and often leads to death if not treated.
Request Sample Copy of Sarcopenia Treatment Report @
Radius Health Inc., GlaxoSmithKline, Abbott Laboratories, Five Prime Therapeutics, Inc., Pfizer Inc., Sanofi S.A., Bayer AG, Nestle S.A., and Novartis AG, Cadila Healthcare Ltd.
Key Market Drivers:
The growing aging population is a key factor driving growth of the Sarcopenia treatment market. According to the United Nation, there were 703 million persons aged 65 years or over in the world in 2019. The number of older persons is projected to double to 1.5 billion in 2050. Moreover, rising awareness regarding Sarcopenia treatment is again fostering the growth of the market.
Increasing investment by key players in the research & development activities of this treatment is expected to augment growth of the market. For instance, in March 2018, Biophytis demonstrated results of Sarconeos (BIO101) for treating sarcopenia, and announced patient enrollment for the SARA-INT international clinical study, at the 8th International Conference on Frailty & Sarcopenia Research (ICFSR).
Covid-19 Impact Analysis
The Covid-19 pandemic has handicapped the entire world due to various restrictions on logistics and production but an upsurge in the healthcare sector, especially in pharma industry. The increasing number of lifestyle diseases due to lack of physical activities during lockdown has led to sarcopenia especially among the aging population. This has created high demand for sarcopenia treatment drugs during the COVID-19 pandemic.
Request PDF Report Brochure @
The Sarcopenia treatment is expected to exhibit a CAGR of XX % over the forecast period, owing to the continuous launch of a novel drug to cater to growing demand. Also, growing various lifestyle associated disease is again propelling growth of the market.
North America is expected to witness strong growth in the market in the near future owing to growing research & development activities. For instance, in February 2021, MYOS CORP, a research-based advanced Nutrition Company with divisions that address both Human Nutrition and Animal Health, announced that it has been granted United States Patent #10,925,904 by the United States Patent and Trademark Office (USPTO)
Key Questions Answered in This Report on Sarcopenia Treatment Market
• How much revenue will the global Sarcopenia Treatment Market generate by the end of the forecast period?
• What regions currently contribute the maximum share to the overall Sarcopenia Treatment Market?
• What are the indicators expected to drive the global Sarcopenia Treatment Market?
• Which region is likely to be a lucrative market during the forecast period?
• What are the essential strategies incorporated by key stakeholders in the global Sarcopenia Treatment Market to expand their geographical presence?
• What are the major advancements witnessed in the global Sarcopenia Treatment Market?
• This report answers these questions and more about the global Sarcopenia Treatment Market, aiding major stakeholders and key players in making the right decisions and strategizing for the advancement of their business.
Buy This Complete A Business Report With Flat US $2000 Off @
Reasons to Purchase this Report
• Current and future of global Sarcopenia Treatment market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Table Of Content
Chapter No. 1 Introduction
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. USP & Key Offerings
1.2. Key Benefits for Stakehulders
1.3. Target Audience
1.4. Report Scope
Chapter No. 2 Executive Summary
2.1. Key Findings
2.1.1. Top Investment Pockets
22.214.171.124. Market Attractiveness Analysis, By Type
126.96.36.199. Market Attractiveness Analysis, By End Use
188.8.131.52. Market Attractiveness Analysis, By Region
2.2. Market Snapshot
2.3. Global Sarcopenia Treatment Market, 2016 – 2021 (USD Million)
2.4. Insights from Primary Respondents
Chapter No. 3 COVID 19 Impact Analysis
3.1. Impact Assessment of COVID-19 Pandemic, By Region
3.1.1. North America
3.1.3. Asia Pacific
3.1.4. Latin America
3.1.5. The Middle-East and Africa
Customization of the Report
In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.
Also, Research Report Examines:
• Competitive companies and manufacturers in global market
• By Product Type, Applications & Growth Factors
• Industry Status and Outlook for Major Applications / End Users / Usage Area
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.
Coherent Market Insights
1001 4th Ave,
#3200 Seattle, WA 98154,U.S.
Phone: US +1-206-701-6702/UK +44-020 8133 4027
- CDN Newswire